Blood Work to Rule Out Pulmonary Lymphoma in a 24-Year-Old Male
Order a complete blood count (CBC), lactate dehydrogenase (LDH), uric acid, comprehensive metabolic panel, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), ferritin, beta-2-microglobulin, and screening for HIV, hepatitis B and C. 1
Essential Laboratory Tests
The ESMO guidelines for DLBCL explicitly recommend the following baseline blood work for lymphoma evaluation 1:
- Complete blood count (CBC) - Look for anemia of inflammation, monocytosis, or reactive thrombocytosis 2, 3
- Lactate dehydrogenase (LDH) - Elevated in 37% of pulmonary lymphoma cases and critical for IPI scoring 1, 4
- Uric acid - Required to assess tumor lysis syndrome risk 1
- Comprehensive metabolic panel - Check for hyponatremia (SIADH can occur with intrathoracic disease), albumin, and transferrin 2
- Protein electrophoresis - Recommended to detect globulin abnormalities 1, 5
Additional Inflammatory and Prognostic Markers
Based on recent case series of pulmonary lymphoma, these markers are frequently abnormal and clinically useful:
- ESR - Elevated in 51% of cases; can be extremely elevated (one case reported 197 mm/h in a 22-year-old) 3, 4
- C-reactive protein (CRP) - Markedly increased in pulmonary lymphoma 6, 2
- Ferritin - Substantially elevated (>1000 ng/mL reported); important marker of inflammation and potential hemophagocytic syndrome 6, 2
- Beta-2-microglobulin - Prognostic marker documented in pulmonary lymphoma cases 3
Infectious Disease Screening
Mandatory screening includes HIV, hepatitis B, and hepatitis C 1. This is non-negotiable before initiating any lymphoma treatment, as these infections alter management and prognosis.
Clinical Context and Pitfalls
Age-Specific Considerations
At 24 years old, this patient is relatively young for lymphoma, but primary pulmonary Hodgkin's lymphoma has been documented in a 22-year-old who was completely asymptomatic except for laboratory abnormalities 3. The incidence of DLBCL increases dramatically with age, but younger patients are not immune 1.
Early Laboratory Changes
Critical pitfall: Anemia of inflammation and monocytosis may precede pulmonary symptoms by up to 6 months 2. If your patient has unexplained anemia of inflammatory disease, occult pulmonary lymphoma should be in your differential even without respiratory complaints.
Hemophagocytic Syndrome
Ferritin >1000 ng/mL combined with other cytopenias should raise suspicion for hemophagocytic lymphohistiocytosis (HLH), which can complicate pulmonary lymphoma 6. Consider adding soluble IL-2 receptor and triglycerides if ferritin is markedly elevated.
What Blood Work Cannot Do
Blood work alone cannot rule out pulmonary lymphoma - normal laboratory values do not exclude the diagnosis. One case report documented primary pulmonary DLBCL with completely normal chest CT but diffuse PET hypermetabolism 6. The definitive diagnosis requires tissue biopsy guided by imaging findings 7, 1.
The IPI score (calculated from age, LDH, performance status, stage, and extranodal sites) correlates with treatment response and should be calculated once lymphoma is confirmed 1, 8.